查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1465214

安氟烷市場：按途徑、最終用途分類 - 2024-2030 年全球預測

Enflurane Market by Route of Administration (Inhalation, Oral), End-Use (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年安氟醚市場規模為2.0639億美元，預計2024年將達2.157億美元，2030年將達2.827億美元，複合年成長率為4.59%。

安氟醚（化學名稱：2-氯-1,1,2-三氟乙基二氟甲基醚）是一種吸入性麻醉劑，歷史上曾在醫學上用於誘導和維持全身麻醉。它的作用是調節中樞神經系統中各種神經傳導物質系統的活動，導致可逆的意識和感覺喪失。安氟醚因其良好的藥物動力學特徵（包括起效和作用時間適中）而一度廣泛用於外科手術，但由於安全性和有效性提高的新型藥物的開發，其使用量隨著時間的推移而減少。全球外科手術的增加、醫療實踐的進步以及醫療保健基礎設施的大量投資推動了對安氟醚的需求。儘管面臨嚴格的監管標準、潛在副作用以及來自安全性更高的新型麻醉劑的競爭等挑戰，安氟醚市場仍提供了充滿希望的成長機會。這包括探索減少副作用的先進、安全的麻醉劑配方，利用資料分析和人工智慧等技術創新進行精確劑量，以及擴展到醫療保健標準不斷提高的新興市場。專注於環保替代品和奈米技術用於靶向藥物傳輸的潛在整合的研究和創新預計將加強市場成長軌跡，同時解決環境問題並改善患者的治療結果。

主要市場統計
基準年[2023] 20639萬美元
預測年份 [2024] 2.157 億美元
預測年份 [2030] 2.827 億美元
複合年成長率（%） 4.59%

給藥途徑：經由吸入增加安氟烷給藥量

安氟醚主要透過吸入給藥。一種強效吸入麻醉劑，用於誘導及維持全身麻醉。當透過吸入給藥時，安氟烷直接從呼吸系統吸收，可以快速誘導麻醉。此途徑是優選的，因為它可以在手術過程中更好地控制麻醉深度。仔細監測呼吸功能和麻醉劑濃度對於確保病人安全和有效的麻醉管理至關重要。安氟醚有口服給藥途徑。可以開處方或建議口服安氟醚。口服攝入為充分麻醉提供了適當的機制。

最終用途：改進安氟醚在醫院的使用方式

由於新型、肝毒性較小且代謝快速的吸入麻醉劑的開發，安氟烷在門診手術中心較少使用。然而，不能完全排除安氟醚在資源匱乏地區和某些患者群體中的作用。在這些機構中，患者的早期復健和出院是首要任務，因此應使用能快速從體內清除且術後副作用最小的麻醉劑。醫院是使用安氟醚的主要場所，特別是在更專業的外科或加護病房病房，可以密切監測其使用情況。由於其功效和成本效益，在某些情況下可以選擇安氟烷。由於擔心腎毒性和可能誘發癲癇發作，特別是在易患癲癇的患者中，安氟醚的受歡迎程度有所下降，特別是由於新藥價格昂貴或無法獲得，在一些國家，它仍然被用作麻醉劑武器。

區域洞察

由於醫療基礎設施強大、人均醫療成本高以及重視需要全身麻醉的外科手術，安氟醚在美洲擁有龐大的市場。在歐盟（EU），成員國之間醫療保健政策的差異正在影響安氟醚的市場滲透率。政府在醫療保健方面支出較高的國家在麻醉方案中使用安氟醚的比例較高。 EMEA（歐洲、中東和非洲）地區擁有多元化的市場，從擁有先進醫療設施的石油國家到醫療基礎設施有限的新興經濟體。在沒有財力的地區，麻醉劑的使用可能不會有進展。在亞太地區，由於醫療產業的快速擴張和外科手術的激增，安氟烷市場正在不斷發展。印度安氟醚市場受到醫療保健基礎設施成長、醫療保健設施使用改善以及成本敏感性的影響。負擔能力和功效之間的平衡對於安氟醚在印度市場的普及起著關鍵作用。

FPNV定位矩陣

FPNV定位矩陣對於評估安氟醚市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對安氟醚市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1. 安氟烷市場規模和預測是多少？

2.安氟烷市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3. 安氟烷市場的技術趨勢和法規結構是什麼？

4.安氟醚市場主要廠商的市場佔有率是多少？

5.進入安氟醚市場的合適型態和戰略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球慢性病和事故的發生率正在增加
      • 安氟烷越來越受到麻醉師用於需要短期至中期麻醉的手術的青睞
    • 抑制因素
      • 新型先進麻醉劑的出現
    • 機會
      • 麻醉管理和監測技術的創新
      • 正在進行生物分解性和環保替代品的研究
    • 任務
      • 安氟烷使用的監管監督和嚴格指南
  • 市場區隔分析
    • 給藥途徑：經由吸入增加安氟醚的劑量
    • 最終用途：醫院使用安氟烷方式的演變
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 安氟醚市場：依給藥途徑

  • 吸入
  • 口服

第7章 安氟醚市場：依最終用途

  • 門診手術中心
  • 醫院

第8章 美洲安氟醚市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區安氟烷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲安氟醚市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • SunMed 完成對 Viair Medical 呼吸和麻醉耗材業務的收購
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-F97DD5A7D999

[180 Pages Report] The Enflurane Market size was estimated at USD 206.39 million in 2023 and expected to reach USD 215.70 million in 2024, at a CAGR 4.59% to reach USD 282.70 million by 2030.

Enflurane, chemically designated as 2-chloro-1,1,2-trifluoroethyl difluoromethyl ether, is an inhalational anesthetic historically utilized in medicine to induce and maintain general anesthesia. It operates by modulating the activity of various neurotransmitter systems in the central nervous system, leading to a reversible loss of consciousness and sensation. While enflurane was once widely used in surgical settings for its advantageous pharmacokinetic profile, including a moderate onset and duration of action, its application has diminished over time due to the development of newer agents with improved safety and efficacy profiles. Enflurane's need is driven by the increasing number of surgical interventions worldwide, advancements in medical practices, and significant investments in healthcare infrastructure. Despite facing challenges such as stringent regulatory standards, potential side effects, and competition from newer anesthetics with improved safety profiles, the enflurane market holds promising growth opportunities. These include the exploration of advanced, safer anesthetic formulations with reduced side effects, leveraging technological innovations such as data analytics and AI for precision dosing, and expanding into emerging markets with rising healthcare standards. Research and innovation focusing on eco-friendly alternatives and the potential integration of nanotechnology for targeted drug delivery represent transformative directions for enhancing the market's growth trajectory while addressing environmental concerns and improving patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 206.39 million
Estimated Year [2024] USD 215.70 million
Forecast Year [2030] USD 282.70 million
CAGR (%) 4.59%

Route of Administration: Increasing administration of enflurane via inhalation

Enflurane is primarily administered through inhalation. It is a potent inhalational anesthetic agent for general anesthesia induction and maintenance. Inhalation administration allows enflurane to be directly absorbed through the respiratory system, providing a rapid onset of anesthesia. This route is preferred for its controllability and the capacity to adjust the depth of anesthesia during surgical procedures. Careful monitoring of respiratory function and anesthetic concentration is critical to ensure patient safety and effective anesthesia management. The oral route of administration is applicable for enflurane. Enflurane is sometimes formulated or recommended for oral consumption. Oral consumption provides an appropriate mechanism for adequate anesthesia.

End-Use: Evolving usage of enflurane by hospitals

In ambulatory surgical centers, enflurane is infrequently used due to the development of newer, less hepatotoxic, and more rapidly metabolized inhalational anesthetics. However, its role in certain low-resource settings or specific patient populations cannot be entirely discounted. These centers prioritize quick patient recovery and discharge, necessitating using anesthetics that allow rapid clearance from the body and minimal post-operative side effects. Hospitals represent a primary setting for administering enflurane, particularly in more specialized surgical or intensive care units where its use can be closely monitored. Enflurane may be chosen for its potency and cost-effectiveness in specific scenarios. Despite its declining popularity due to concerns over nephrotoxicity and the potential for seizure induction, especially in patients predisposed to epilepsy, it remains in the arsenal of anesthetics, particularly in countries where newer agents are prohibitively expensive or unavailable.

Regional Insights

In the Americas, enflurane has a significant market driven by robust healthcare infrastructure, high per capita healthcare expenditure, and a strong emphasis on surgical procedures requiring general anesthesia. In the European Union, varying healthcare policies across member states affect enflurane's market penetration. Nations with more significant governmental healthcare spending exhibit higher rates of enflurane utilization in anesthesia protocols. The EMEA region presents a diverse market ranging from oil-rich nations with advanced healthcare facilities to developing economies with limited medical infrastructure. Affordability issues may drive its use in less affluent areas. In the Asia Pacific, the enflurane market is evolving due to the rapidly expanding healthcare sector and surge in surgical procedures. India's market for enflurane is influenced by its growing healthcare infrastructure, increased accessibility to medical facilities, and cost sensitivity. The balance between affordability and efficacy plays a critical role in enflurane's adoption in the Indian market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Enflurane Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Enflurane Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Enflurane Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International, Inc., Boehringer Ingelheim International GmbH, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies Inc., Hikma Pharmaceuticals PLC, J&TEC CO., LTD., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Enflurane Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Inhalation
    • Oral
  • End-Use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Enflurane Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Enflurane Market?

3. What are the technology trends and regulatory frameworks in the Enflurane Market?

4. What is the market share of the leading vendors in the Enflurane Market?

5. Which modes and strategic moves are suitable for entering the Enflurane Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of chronic diseases and accidents globally
      • 5.1.1.2. Increasing preference for enflurane among anesthesiologists for surgeries requiring short- to medium-term anesthesia
    • 5.1.2. Restraints
      • 5.1.2.1. Emergence of newer and advanced anesthetic agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations in anesthesia delivery and monitoring techniques
      • 5.1.3.2. Ongoing research into biodegradable, eco-friendly alternatives
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory scrutiny and stringent guidelines governing the use of enflurane
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Route of Administration: Increasing administration of enflurane via inhalation
    • 5.2.2. End-Use: Evolving usage of enflurane by hospitals
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Enflurane Market, by Route of Administration

  • 6.1. Introduction
  • 6.2. Inhalation
  • 6.3. Oral

7. Enflurane Market, by End-Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Enflurane Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Enflurane Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Enflurane Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. SunMed Completes Acquisition Of Respiratory & Anesthesia Consumables Business Of Vyaire Medical
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ENFLURANE MARKET RESEARCH PROCESS
  • FIGURE 2. ENFLURANE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ENFLURANE MARKET DYNAMICS
  • FIGURE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ENFLURANE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ENFLURANE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ENFLURANE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ENFLURANE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ENFLURANE MARKET SIZE, BY INHALATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ENFLURANE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ENFLURANE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ENFLURANE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 20. AMERICAS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 21. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 22. AMERICAS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 23. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 24. AMERICAS ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 25. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 26. ARGENTINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 27. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 28. ARGENTINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 29. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 30. BRAZIL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 31. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 32. BRAZIL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 33. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 34. CANADA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 35. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 36. CANADA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 37. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 38. MEXICO ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 39. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 40. MEXICO ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 41. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 42. UNITED STATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 43. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 44. UNITED STATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 45. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 46. UNITED STATES ENFLURANE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 54. AUSTRALIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 56. AUSTRALIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 57. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 58. CHINA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 59. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 60. CHINA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 61. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. INDIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 64. INDIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 65. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 66. INDONESIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 68. INDONESIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 69. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 70. JAPAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 71. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 72. JAPAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 73. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 74. MALAYSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 75. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. MALAYSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 78. PHILIPPINES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 80. PHILIPPINES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 81. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 82. SINGAPORE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 83. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 84. SINGAPORE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 86. SOUTH KOREA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 88. SOUTH KOREA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 89. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 90. TAIWAN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 91. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 92. TAIWAN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 93. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 94. THAILAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 95. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. THAILAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 98. VIETNAM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 99. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 100. VIETNAM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ENFLURANE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 107. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. DENMARK ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 110. DENMARK ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 111. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 112. EGYPT ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 113. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 114. EGYPT ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 115. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 116. FINLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 117. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. FINLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. FRANCE ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 122. FRANCE ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 123. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 124. GERMANY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 125. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 126. GERMANY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 127. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 128. ISRAEL ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 129. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. ISRAEL ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. ITALY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 134. ITALY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 136. NETHERLANDS ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 138. NETHERLANDS ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 139. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 140. NIGERIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 141. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 142. NIGERIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 143. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. NORWAY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 146. NORWAY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 147. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 148. POLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 149. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. POLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 152. QATAR ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 153. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 154. QATAR ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 155. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 156. RUSSIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 157. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 158. RUSSIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 160. SAUDI ARABIA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 162. SAUDI ARABIA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 164. SOUTH AFRICA ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 166. SOUTH AFRICA ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 167. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 168. SPAIN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 169. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. SPAIN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 172. SWEDEN ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 173. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 174. SWEDEN ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 176. SWITZERLAND ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 178. SWITZERLAND ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 179. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 180. TURKEY ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 181. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 182. TURKEY ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 188. UNITED KINGDOM ENFLURANE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED KINGDOM ENFLURANE MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. ENFLURANE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. ENFLURANE MARKET, FPNV POSITIONING MATRIX, 2023